Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Austin Schinlever"'
Autor:
Sean Cuddy, Austin Schinlever, Sara Dochnal, Jon Suzich, Mina Farah, Chris Boutell, Anna Ruth Cliffe
Publikováno v:
Proceedings, Vol 50, Iss 1, p 91 (2020)
Herpes Simplex Virus (HSV) establishes a latent infection in neurons, in which viral transcription is restricted and viral promoters are associated with heterochromatin. In response to certain stimuli, the virus reactivates to permit transmission. Th
Externí odkaz:
https://doaj.org/article/6239b73f2b7d4083b7912668e22d58c9
Autor:
Maren de Vries, Fabrice Bailly, Philippe Cotelle, Ramanjit Kaur, Meike Dittmann, Sheena Faye Garcia, Hailey V Goldberg, Bearach Miwatani-Minter, Gergely Róna, Hui Wang, András Zeke, Ning Zheng, Nathaniel R. Landau, Thomas R. Hinds, Michele Pagano, Austin Schinlever, Didier Desmaële
Publikováno v:
Cell Death and Differentiation
The risk of zoonotic coronavirus spillover into the human population, as highlighted by the SARS-CoV-2 pandemic, demands the development of pan-coronavirus antivirals. The efficacy of existing antiviral ribonucleoside/ribonucleotide analogs, such as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6fc032e3aa253b0779f0e3ef0ce6490
https://doi.org/10.1038/s41418-021-00900-1
https://doi.org/10.1038/s41418-021-00900-1
Autor:
Joseph C. Devlin, Ellie Ivanova, Joseph John Binder, Rachel A Prescott, Annaliesa S. Anderson, Claire M. Steppan, Ana M. Valero-Jimenez, Alberto Herrera, Austin Schinlever, Meike Dittmann, Kelly V. Ruggles, Paige Loose, Adil Mohamed, Ludovic Desvignes, Sergei B. Koralov, Rebecca E. O’Connor, Maren de Vries
Publikováno v:
Journal of Virology. 95
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent of Coronavirus Disease 2019 (COVID-19). There is a dire need for novel effective antivirals to treat COVID-19, as the only approved direct-acting antiviral to date
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea53373c54a9220d70405d71a78a5dc8
https://doi.org/10.1128/jvi.01819-20
https://doi.org/10.1128/jvi.01819-20
Autor:
Maren, de Vries, Adil S, Mohamed, Rachel A, Prescott, Ana M, Valero-Jimenez, Ludovic, Desvignes, Rebecca, O'Connor, Claire, Steppan, Joseph C, Devlin, Ellie, Ivanova, Alberto, Herrera, Austin, Schinlever, Paige, Loose, Kelly, Ruggles, Sergei B, Koralov, Annaliesa S, Anderson, Joseph, Binder, Meike, Dittmann
Publikováno v:
bioRxiv
article-version (status) pre
article-version (number) 1
article-version (status) pre
article-version (number) 1
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent of Coronavirus Disease 2019 (COVID-19), a pandemic that has claimed over 700,000 human lives. The only SARS-CoV-2 antiviral, for emergency use, is remdesivir, targe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::32162a129b8ca6458ade4e20e54edace
https://pubmed.ncbi.nlm.nih.gov/32869028
https://pubmed.ncbi.nlm.nih.gov/32869028
Autor:
Maren, de Vries, Adil S, Mohamed, Rachel A, Prescott, Ana M, Valero-Jimenez, Ludovic, Desvignes, Rebecca, O'Connor, Claire, Steppan, Joseph C, Devlin, Ellie, Ivanova, Alberto, Herrera, Austin, Schinlever, Paige, Loose, Kelly, Ruggles, Sergei B, Koralov, Annaliesa S, Anderson, Joseph, Binder, Meike, Dittmann
Publikováno v:
Journal of Virology
The arsenal of SARS-CoV-2 specific antiviral drugs is extremely limited. Only one direct-acting antiviral drug is currently approved, the viral polymerase inhibitor remdesivir, and it has limited efficacy.
Severe acute respiratory syndrome coron
Severe acute respiratory syndrome coron
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c36a83d34fc593cab661bb7305ef3326
https://pubmed.ncbi.nlm.nih.gov/33622961
https://pubmed.ncbi.nlm.nih.gov/33622961
Autor:
Claire M. Steppan, Annaliesa S. Anderson, Paige Loose, Ana M. Valero-Jimenez, Alberto Herrera, Joseph C. Devlin, Meike Dittmann, Adil Mohamed, Sergei B. Koralov, Rachel A Prescott, Maren de Vries, Austin Schinlever, Ellie Ivanova, Ludovic Desvignes, Kelly V. Ruggles, Rebecca E. O’Connor, Joseph John Binder
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent of Coronavirus Disease 2019 (COVID-19). There is a dire need for novel effective antivirals to treat COVID-19, as the only approved direct-acting antiviral to date
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05673af55dcb1fd9e0c28b2ca15add42
https://doi.org/10.1101/2020.08.28.272880
https://doi.org/10.1101/2020.08.28.272880
